Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $87,113 - $105,157
324 Added 22.69%
1,752 $498,000
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $24,547 - $27,692
96 Added 7.21%
1,428 $411,000
Q3 2023

Oct 25, 2023

SELL
$218.65 - $271.46 $8,090 - $10,044
-37 Reduced 2.7%
1,332 $357,000
Q2 2023

Jul 18, 2023

SELL
$214.27 - $253.37 $23,569 - $27,870
-110 Reduced 7.44%
1,369 $303,000
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $21,224 - $25,868
94 Added 6.79%
1,479 $357,000
Q4 2022

Jan 31, 2023

BUY
$229.03 - $291.01 $24,048 - $30,556
105 Added 8.2%
1,385 $363,000
Q3 2022

Nov 02, 2022

SELL
$224.46 - $253.15 $4,040 - $4,556
-18 Reduced 1.39%
1,280 $288,000
Q2 2022

Jul 18, 2022

SELL
$230.71 - $256.74 $1,153 - $1,283
-5 Reduced 0.38%
1,298 $316,000
Q1 2022

May 02, 2022

SELL
$219.27 - $242.57 $2,850 - $3,153
-13 Reduced 0.99%
1,303 $315,000
Q4 2021

Jan 26, 2022

SELL
$198.88 - $227.6 $31,025 - $35,505
-156 Reduced 10.6%
1,316 $296,000
Q3 2021

Oct 18, 2021

BUY
$212.27 - $248.7 $12,099 - $14,175
57 Added 4.03%
1,472 $313,000
Q2 2021

Jul 22, 2021

SELL
$233.58 - $259.14 $14,949 - $16,584
-64 Reduced 4.33%
1,415 $345,000
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $16,421 - $19,136
74 Added 5.27%
1,479 $368,000
Q4 2020

Mar 08, 2021

BUY
$216.38 - $257.67 $11,900 - $14,171
55 Added 4.07%
1,405 $323,000
Q3 2020

Nov 04, 2020

BUY
$234.65 - $260.95 $38,247 - $42,534
163 Added 13.73%
1,350 $343,000
Q2 2020

Jul 28, 2020

SELL
$197.81 - $242.74 $13,846 - $16,991
-70 Reduced 5.57%
1,187 $280,000
Q1 2020

Apr 23, 2020

BUY
$182.24 - $241.7 $20,957 - $27,795
115 Added 10.07%
1,257 $255,000
Q4 2019

Jan 28, 2020

BUY
$189.21 - $243.2 $216,077 - $277,734
1,142 New
1,142 $275,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kfa Private Wealth Group, LLC Portfolio

Follow Kfa Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kfa Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kfa Private Wealth Group, LLC with notifications on news.